Literature DB >> 12175663

Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.

Q Qiao1, K Pyörälä, M Pyörälä, A Nissinen, J Lindström, R Tilvis, J Tuomilehto.   

Abstract

AIMS: To assess the predictive value of fasting and 2-h glucose after a 75 g glucose load, with regard to incidence of coronary heart disease and cardiovascular mortality. METHODS AND
RESULTS: 6766 subjects from five Finnish cohorts aged 30-89 years were followed up for 7-10 years. Hazards ratios associated with increasing glucose concentrations were homogeneous over studies. Multivariate Cox regression analyses showed that the hazards ratio for one standard deviation increase in 2-h glucose after logarithmic transformation was 1.17 (95% CI 1.05-1.30) for coronary heart disease incidence and 1.22 (1.09-1.37) for cardiovascular mortality. For fasting glucose, they were 1.05 (0.94-1.17) and 1.13 (1.01-1.25), respectively. Inclusion of 2-h glucose in the model based on fasting glucose significantly improved the prediction (P<0.005 for coronary heart disease incidence and P<0.025 for cardiovascular mortality), whereas fasting glucose did not add significant information to the model initially based on 2-h glucose (P>0.10 for both events).
CONCLUSION: In subjects without a prior history of diabetes the association of 2-h glucose with coronary heart disease incidence and cardiovascular morality is graded and independent. The results of our study indicate that 2-h glucose is superior to fasting glucose in assessing the risk of future cardiovascular disease events. Copyright 2002 The European Society of Cardiology Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175663     DOI: 10.1053/euhj.2001.3113

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  44 in total

1.  Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey.

Authors:  Dan Ziegler; Andreas Voss; Wolfgang Rathmann; Alexander Strom; Siegfried Perz; Michael Roden; Annette Peters; Christa Meisinger
Journal:  Diabetologia       Date:  2015-02-28       Impact factor: 10.122

Review 2.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

3.  Bivariate genetic modelling of the response to an oral glucose tolerance challenge: a gene x environment interaction approach.

Authors:  G F Liu; H Riese; T D Spector; M Mangino; S D O'Dell; R P Stolk; H Snieder
Journal:  Diabetologia       Date:  2009-03-14       Impact factor: 10.122

Review 4.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

5.  Effective Translation of an Intensive Lifestyle Intervention for Hispanic Women With Prediabetes in a Community Health Center Setting.

Authors:  Michelle A Van Name; Anne W Camp; Elizabeth A Magenheimer; Fangyong Li; James D Dziura; Abmaridel Montosa; Anisha Patel; William V Tamborlane
Journal:  Diabetes Care       Date:  2016-02-23       Impact factor: 19.112

6.  Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program.

Authors:  Katherine A Pratte; Ann Johnson; Janette Beals; Ann Bullock; Spero M Manson; Luohua Jiang
Journal:  Diabetes Care       Date:  2019-06-08       Impact factor: 19.112

7.  Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.

Authors:  Masafumi Ueno; Kosuke Fujita; Hiroyuki Yamamoto; Tomoyuki Ikeda; Tatsuya Suga; Kenji Yamaji; Shinichiro Ikuta; Kazuhiro Kobuke; Yoshitaka Iwanaga; Dominick J Angiolillo; Shunichi Miyazaki
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

8.  Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range.

Authors:  Feng Ning; Jaakko Tuomilehto; Kalevi Pyörälä; Altan Onat; Stefan Söderberg; Qing Qiao
Journal:  Diabetes Care       Date:  2010-04-27       Impact factor: 19.112

9.  Inhaled Technosphere insulin in comparison to subcutaneous regular human insulin: time action profile and variability in subjects with type 2 diabetes.

Authors:  Klaus Rave; Tim Heise; Lutz Heinemann; Anders H Boss
Journal:  J Diabetes Sci Technol       Date:  2008-03

10.  Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetes.

Authors:  Cees J Tack; Vladimir Christov; Bastiaan E de Galan; Karl-Michael Derwahl; Gerhard Klausmann; Terezie Pelikánová; Jindra Perusicová; Anders H Boss; Nikhil Amin; David Kramer; Richard Petrucci; Wen Yu
Journal:  J Diabetes Sci Technol       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.